XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock Series A [Member]
Preferred Stock Series B [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 67,191 $ 475,000 $ 12,551 $ (13) $ 73,055,579 $ (86,164,319) $ (371,909) $ (12,925,920)
Beginning balance, shares at Dec. 31, 2021 67,191 475,000 125,509,810 133,200        
Conversion of Series A to common stock $ (9,011) $ 1,126 7,885
Conversion of Series A to common stock, shares (9,011)   11,263,750          
Conversion of convertible notes to common stock $ 2,819 499,096 501,915
Conversion of convertible notes to common stock, shares     28,186,741          
Sale of common stock in private placement $ 250 39,765 40,015
Sale of common stock in private placement, shares     2,500,000          
Commitment shares issued with convertible note $ 100 16,900 17,000
Commitment shares issued with convertible note, shares     1,000,000          
Beneficial conversion feature of convertible notes 227,386 227,386
Stock based compensation related to warrant issuances 45,245 45,245
Foreign currency translation adjustment (120,750) (120,750)
Net loss (2,071,982) (2,071,982)
Ending balance, value at Mar. 31, 2022 $ 58,180 $ 475,000 $ 16,846 $ (13) 73,891,856 (88,236,301) (492,659) (14,287,091)
Ending balance, shares at Mar. 31, 2022 58,180 475,000 168,460,301 133,200        
Beginning balance, value at Dec. 31, 2021 $ 67,191 $ 475,000 $ 12,551 $ (13) 73,055,579 (86,164,319) (371,909) (12,925,920)
Beginning balance, shares at Dec. 31, 2021 67,191 475,000 125,509,810 133,200        
Net loss               (4,891,559)
Ending balance, value at Sep. 30, 2022 $ 52,416 $ 2,475,000 $ 25,757 $ (13) 73,211,704 (91,055,878) 306,285 (14,984,729)
Ending balance, shares at Sep. 30, 2022 52,416 2,475,000 257,569,176 133,200        
Beginning balance, value at Mar. 31, 2022 $ 58,180 $ 475,000 $ 16,846 $ (13) 73,891,856 (88,236,301) (492,659) (14,287,091)
Beginning balance, shares at Mar. 31, 2022 58,180 475,000 168,460,301 133,200        
Conversion of convertible notes to common stock $ 2,398 327,201 329,599
Conversion of convertible notes to common stock, shares     23,987,460          
Sale of common stock in private placement $ 2,500 247,497 249,997
Sale of common stock in private placement, shares     25,000,000          
Commitment shares issued for equity line of credit $ 1,000 129,000 130,000
Commitment shares issued for equity line of credit, shares     10,000,000          
Beneficial conversion feature of convertible notes 64,414 64,414
Stock based compensation related to warrant issuances 45,245 45,245
Foreign currency translation adjustment 270,004 270,004
Net loss (1,506,329) (1,506,329)
Ending balance, value at Jun. 30, 2022 $ 58,180 $ 475,000 $ 22,744 $ (13) 74,705,213 (89,742,630) (222,655) (14,704,161)
Ending balance, shares at Jun. 30, 2022 58,180 475,000 227,447,761 133,200        
Conversion of convertible notes to common stock $ 2,292 346,463 348,755
Conversion of convertible notes to common stock, shares     22,916,415          
Conversion of Series A Preferred to common stock $ (13,764) $ 1,721 12,044 1
Conversion of Series A Preferred to common stock, shares (13,764)   17,205,000          
Conversion of common shares issued for equity line of credit to Series A Preferred $ 8,000 $ (1,000) (7,000)
Conversion of common shares issued for equity line of credit to Series A Preferred, shares 8,000   (10,000,000)          
Issuance of Series B Preferred for deposit on acquisition $ 2,000,000 (1,944,011) 55,989
Issuance of Series B Preferred for deposit on acquisition, shares   2,000,000            
Beneficial conversion feature of convertible notes 53,750 53,750
Stock based compensation related to warrant issuances 45,245 45,245
Foreign currency translation adjustment 528,940 528,940
Net loss (1,313,248) (1,313,248)
Ending balance, value at Sep. 30, 2022 $ 52,416 $ 2,475,000 $ 25,757 $ (13) 73,211,704 (91,055,878) 306,285 (14,984,729)
Ending balance, shares at Sep. 30, 2022 52,416 2,475,000 257,569,176 133,200        
Beginning balance, value at Dec. 31, 2022 $ 84,416 $ 2,475,000 $ 27,412 $ (13) 74,523,642 (94,695,339) 240,426 (17,344,456)
Beginning balance, shares at Dec. 31, 2022 84,416 2,475,000 274,124,622 133,200        
Conversion of Series B to common stock $ (20,000) $ 2 19,998
Conversion of Series B to common stock, shares   (20,000) 20,000          
Conversion of convertible notes to common stock $ 2,062 504,953 507,015
Conversion of convertible notes to common stock, shares     20,619,992          
Stock-based compensation 45,245 45,245
Foreign currency translation adjustment (5,656) (5,656)
Net loss (1,412,573) (1,412,573)
Ending balance, value at Mar. 31, 2023 $ 84,416 $ 2,455,000 $ 29,476 $ (13) 75,093,838 (96,107,912) 234,770 (18,210,425)
Ending balance, shares at Mar. 31, 2023 84,416 2,455,000 294,764,614 133,200        
Beginning balance, value at Dec. 31, 2022 $ 84,416 $ 2,475,000 $ 27,412 $ (13) 74,523,642 (94,695,339) 240,426 (17,344,456)
Beginning balance, shares at Dec. 31, 2022 84,416 2,475,000 274,124,622 133,200        
Net loss               (3,856,525)
Ending balance, value at Sep. 30, 2023 $ 84,416 $ 2,455,000 $ 29,476 $ 597 75,247,742 (98,551,864) 104,658 (20,629,975)
Ending balance, shares at Sep. 30, 2023 84,416 2,455,000 294,764,614 6,230,761        
Beginning balance, value at Mar. 31, 2023 $ 84,416 $ 2,455,000 $ 29,476 $ (13) 75,093,838 (96,107,912) 234,770 (18,210,425)
Beginning balance, shares at Mar. 31, 2023 84,416 2,455,000 294,764,614 133,200        
Conversion of convertible notes to common stock $ 610 63,415 64,025
Conversion of convertible notes to common stock, shares     6,097,561          
Stock-based compensation 45,244 45,244
Foreign currency translation adjustment (163,244) (163,244)
Net loss (1,879,584) (1,879,584)
Ending balance, value at Jun. 30, 2023 $ 84,416 $ 2,455,000 $ 30,086 $ (13) 75,202,497 (97,987,496) 71,526 (20,143,984)
Ending balance, shares at Jun. 30, 2023 84,416 2,455,000 300,862,175 133,200        
Common stock returned to treasury $ (610) $ 610
Common stock returned to treasury, shares     (6,097,561) 6,097,561        
Stock-based compensation 45,245 45,245
Foreign currency translation adjustment 33,132 33,132
Net loss (564,368) (564,368)
Ending balance, value at Sep. 30, 2023 $ 84,416 $ 2,455,000 $ 29,476 $ 597 $ 75,247,742 $ (98,551,864) $ 104,658 $ (20,629,975)
Ending balance, shares at Sep. 30, 2023 84,416 2,455,000 294,764,614 6,230,761